Table 3.
Univariate and multivariate Cox analysis of clinical factors and overall survival in SKCM patients.
| Clinical factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Age | 1.0193 (1.0084–1.0302) | 0.0005 | 1.0133 (1.0022–1.0245) | 0.0183 |
| Gender | 1.0291 (0.7378–1.4355) | 0.8657 | 1.0430 (0.7438–1.4624) | 0.8073 |
| Stage | 1.3961 (1.1673–1.6699) | 0.0003 | 1.0110 (0.7896–1.2945) | 0.9311 |
| T stage | 1.3380 (1.1730–1.5261) | <0.0001 | 1.3017 (1.1350–1.4929) | 0.0002 |
| M stage | 1.7568 (0.7174–4.3020) | 0.2175 | 1.4131 (0.5433–3.6751) | 0.4783 |
| N stage | 1.4202 (1.2137–1.6620) | <0.0001 | 1.4847 (1.1913–1.8504) | 0.0004 |
| TBX21 | 0.6911 (0.5745–0.8315) | <0.0001 | 0.7265 (0.6058–0.8713) | 0.0006 |
HR – hazard ratio; CI – confidence interval; SKCM – skin cutaneous melanoma P<0.05 was statistically significant, and P-value less than 0.05 in the table are shown in bold.